TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse.

Aleix Prat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.